Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2692-2014Class II

ABX PENTRA Magnesium RTU Reagent, Part No. A11A01646

Horiba Instruments Incorporated / initiated 2014-08-11 / Terminated / root cause: labeling and UDI

Horiba Instruments, Inc dba Horiba Medical began a recall of ABX PENTRA Magnesium RTU Reagent, Part No. A11A01646 Product Usage: ABX PENTRA Magnesium RTU reagent with associated calibrators and controls are for... on . FDA classified it as Class II and gives the reason as "Horiba Medical is recalling the ABX PENTRA Magnesium RTU Reagent because the on-board stability claims has been updated. Horiba has updated the ABX PENTRA Magnesium RTU package inserts by removing the 7-day on-board...". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-2692-2014
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Horiba Instruments Incorporated
Product
ABX PENTRA Magnesium RTU Reagent, Part No. A11A01646 Product Usage: ABX PENTRA Magnesium RTU reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of magnesium in human serum and plasma based on a photometric test using xylidyl blue. Magnesium measurements are used in the diagnosis and treatment of hypomagnesemnia (abnormally low plasma levels of magnesium) and hypermagnesemnia (abnormally high plasma levels of magnesium).
Product code
JGJ Photometric Method, Magnesium
Reason for recall
Horiba Medical is recalling the ABX PENTRA Magnesium RTU Reagent because the on-board stability claims has been updated. Horiba has updated the ABX PENTRA Magnesium RTU package inserts by removing the 7-day on-board stability claim and replacing it with a 1-day on-board stability claim.
Root cause tag
labeling and UDI
FDA root cause
Other
Action
Horiba sent an Urgent Safety Notice letter dated August 11, 2014 to all customers running the Magnesium RTU assay on the ABX PENTRA 400 Chemistry analyzers that the On-Board Stability has been updated. The letter informs the customers of the problems identified and the actions to be taken. Customers are instructed to complete and return the enclosed response form within 10 days. For questions call 888-903-5001, ext 4266.
Quantity in commerce
359 units
Distribution
US Nationwide Distribution.
Product codes and lots
All Lots

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2692-2014
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2692-2014Class IITerminatedVoluntary: Firm initiated